PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 26409001-0 2015 Differential ERK activation during autophagy induced by europium hydroxide nanorods and trehalose: Maximum clearance of huntingtin aggregates through combined treatment. Trehalose 88-97 huntingtin Homo sapiens 120-130 32649191-3 2020 Here we report hyperbranched polyglycerol dendrimer terminated with anti-amyloidogenic small molecules such as gallate, tyrosine and trehalose and their potential in inhibiting lysozyme/huntingtin protein aggregation under intra/extracellular space. Trehalose 133-142 huntingtin Homo sapiens 186-196 26957541-2 2016 Cell treatment with trehalose could decrease cytosolic aggregates of potentially pathogenic proteins, including mutant huntingtin, alpha-synuclein, and phosphorylated tau that are associated with neurodegenerative diseases. Trehalose 20-29 huntingtin Homo sapiens 119-129 28356891-2 2017 Trehalose induces abundant autophagy in cultured cells and also reduces the rate of aggregation of the huntingtin protein in the animal model of Huntington disease, a chronic neurological disease in humans. Trehalose 0-9 huntingtin Homo sapiens 103-113 26409001-6 2015 Interestingly, the combined treatment of EHNs and trehalose leads to more degradation of mutant huntingtin protein aggregates than that obtained with single treatment of either nanorods or trehalose. Trehalose 50-59 huntingtin Homo sapiens 96-106 24587280-8 2014 Treatment with trehalose counteracts the increase in ROS, ubiquitinated proteins, huntingtin and activated caspase-3 levels induced by epoxomicin, and also increases the LC3 levels more in HD fibroblast than controls. Trehalose 15-24 huntingtin Homo sapiens 82-92 17182613-0 2007 Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. Trehalose 0-9 huntingtin Homo sapiens 92-102 17182613-4 2007 Trehalose-induced autophagy enhanced the clearance of autophagy substrates like mutant huntingtin and the A30P and A53T mutants of alpha-synuclein, associated with Huntington disease (HD) and Parkinson disease (PD), respectively. Trehalose 0-9 huntingtin Homo sapiens 87-97